ERNA vs ONCO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

ERNA

47.4
AI Score
VS
ERNA Wins

ONCO

34.3
AI Score

Investment Advisor Scores

ERNA

47score
Recommendation
HOLD

ONCO

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ERNA ONCO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -94.1% -83.9% ONCO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.4/100 34.3/100 ERNA
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ERNA

Relative Price Performance (Last 90 Days)

ERNA 1M: -34.6% · 3M: -53.9% ONCO 1M: +7.1% · 3M: -34.3%

Current Technical Phase

ERNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 26

RSI (14): 26.5 · Price: $2.97

ONCO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $0.72

Fundamentals Snapshot

Metric ERNA ONCO
Market Cap — —
Forward P/E -1.6 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.9% -0.8%
Gross Margin 1.0% 0.8%
Operating Margin 0.0% -131.1%
EPS -0.41 749.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ERNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.